Tevogen Bio Holdings Files 2024 10-K
Ticker: TVGNW · Form: 10-K · Filed: Apr 2, 2025 · CIK: 1860871
| Field | Detail |
|---|---|
| Company | Tevogen Bio Holdings Inc. (TVGNW) |
| Form Type | 10-K |
| Filed Date | Apr 2, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, biotech, financials
TL;DR
Tevogen Bio Holdings filed its 2024 10-K. Details on stock and financials inside.
AI Summary
Tevogen Bio Holdings Inc. filed its 2024 10-K on April 2, 2025, reporting on its fiscal year ending December 31, 2024. The company, formerly Semper Paratus Acquisition Corp., is involved in the biological products sector. Key financial details and specific stock series are mentioned, but no revenue or profit figures are immediately apparent in this excerpt.
Why It Matters
This filing provides investors with the company's annual financial performance and operational overview for the fiscal year 2024, crucial for understanding its current standing and future prospects.
Risk Assessment
Risk Level: medium — As a biotechnology company, Tevogen Bio Holdings likely faces significant risks related to research and development, regulatory approvals, and market competition.
Key Numbers
- 0.0001 — Par Value Per Share (Common stock par value)
- 11.50 — Exercise Price (Warrants exercisable for common stock)
Key Players & Entities
- Tevogen Bio Holdings Inc. (company) — Filer of the 10-K
- Semper Paratus Acquisition Corp. (company) — Former name of Tevogen Bio Holdings Inc.
- 2024-12-31 (date) — Fiscal year end
- 2025-04-02 (date) — Filing date
- 15 Independence Boulevard, Suite 410, Warren, NJ 07059 (address) — Business and mailing address
FAQ
What is the primary business of Tevogen Bio Holdings Inc.?
Tevogen Bio Holdings Inc. is involved in the biological products sector, specifically classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' with SIC code 2836.
When did Tevogen Bio Holdings Inc. change its name?
The company changed its name from Semper Paratus Acquisition Corp. on May 5, 2021.
What is the business address of Tevogen Bio Holdings Inc.?
The business address is 15 Independence Boulevard, Suite 410, Warren, NJ 07059.
What is the par value of Tevogen Bio Holdings Inc.'s common stock?
The par value per share for common stock is $0.0001.
What is the exercise price for the company's warrants?
The warrants are exercisable for one share of common stock at $11.50 per share.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 2, 2025 regarding Tevogen Bio Holdings Inc. (TVGNW).